Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

Organon

Status and phase: Completed; Phase 3

Conditions: Atherosclerotic Disease; Hypercholesterolemia; Coronary Disease

Treatments: Drug: Duration of Treatment: 6 weeks; Drug: Comparator: atorvastatin; Drug: MK0653A , ezetimibe (+) simvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00090168

0653A-806

2004_002

Details and patient eligibility

About

A 6-week treatment study to compare the reduction in cholesterol of two drugs MK0653A+Simvastatin for high cholesterol, in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.

Enrollment: 435 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Men and women greater than or equal to 18 years of age with elevated cholesterol levels and coronary heart disease (CHD), or atherosclerotic vascular disease may be eligible to participate in this study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind